IDiyas

For the Inventor, By the Inventor

Pulheim, Germany

Sigurd Leyck

USPTO Granted Patents = 16

Average Co-Inventor Count = 3.9

ph-index = 6

Forward Citations = 108(Granted Patents)


Location History:

  • Brauweiler, DE (1984)
  • Tubingen, DE (1986)
  • Pulheim, DE (1983 - 1992)

Company Filing History:

goldMedal15 out of 94 
 
A. Nattermann & Cie Gmbh
 patents
silverMedal1 out of 5 
 
Nattermann & Cie Gmbh
 patents

Years Active: 1983-1992

Loading Chart...
16 patents (USPTO):Explore Patents
1. 5141955 - Anti-inflammatory benzylselenobenzamides made from anilines and (1992-08-25),
2. 5114954 - Antiinflammatory benzylselenobenzamides from aminopyridines and (1992-05-19),
3. 4910313 - Diselenobis benzoic acid amides of primary heterocyclic amines, process (1990-03-20),
4. 4730053 - S-[2-phenyl (alkyl) carbamoyl]-phenylselenylmercapto derivatives (1988-03-08),
5. 4711961 - Benzisoselenazolethiones and process for the treatment of various (1987-12-08),
6. 4705802 - Omega-aryl-alkylthienyl-compounds and process for the treatment of (1987-11-10),
7. 4687766 - Pharmaceutical preparation for the therapeutic treatment of rheumatic (1987-08-18),
8. 4684632 - Formulation with special 1,2-diacylglycero-3-phosphocholines for the (1987-08-04),
9. 4667033 - Substituted 6-(thien-2-yl)-3(2H)-pyridazinones (1987-05-19),
10. 4618669 - S-(carbamoyl-phenylselenyl) derivatives of glutathione and of (1986-10-21),
11. 4610979 - O-acyl-alkanediol-phospholipids and processes for the treatment of asthma (1986-09-09),
12. 4600722 - 3-amino-1-(4,5,6,7-tetrahydro-benzothiazolyl)-2-pyrazolines and a (1986-07-15),
13. 4550168 - Benzisoselenazolones and a process for the treatment of inflammatory (1985-10-29),
14. 4464379 - Indol acetic acid derivatives and anti-inflamatory and related uses (1984-08-07),
15. 4454068 - Cycloalkyl derivatives of benzisoselenazolones (1984-06-12),

Title: Sigurd Leyck: Innovator in Anti-Inflammatory Compounds

Introduction

Sigurd Leyck is a notable inventor based in Pulheim, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of anti-inflammatory compounds. With a total of 16 patents to his name, Leyck's work has had a considerable impact on medical research and treatment options.

Latest Patents

Leyck's latest patents include innovative compounds such as anti-inflammatory benzylselenobenzamides made from anilines. These compounds are characterized by their unique formula, where R can be hydrogen, methyl, or ethyl. Additionally, he has developed anti-inflammatory benzylselenobenzamides derived from aminopyridines, which exhibit inflammation-inhibiting characteristics and are utilized in pharmaceutical preparations.

Career Highlights

Throughout his career, Leyck has worked with prominent companies, including A. Nattermann & Cie GmbH. His expertise in the field has allowed him to contribute to various projects that focus on improving health outcomes through innovative pharmaceutical solutions.

Collaborations

Leyck has collaborated with esteemed colleagues such as Andre Welter and Eugen Etschenberg. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in research.

Conclusion

Sigurd Leyck's contributions to the field of pharmaceuticals, particularly in anti-inflammatory compounds, highlight his role as an influential inventor. His patents and collaborations reflect a commitment to advancing medical science and improving patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…